Status:

COMPLETED

Insomnia and Mindfulness Stress Reduction Program

Lead Sponsor:

NURDİLAN SENER

Conditions:

Postmenopausal Symptoms

Eligibility:

FEMALE

50-70 years

Phase:

NA

Brief Summary

Menopause is the longest life stage in a woman's life, in which psychological and social changes are experienced as well as physical changes and some health problems occur. The symptoms of menopause d...

Detailed Description

Menopause is a medical term defined as the absence of menstrual bleeding lasting more than one year in women in a certain period of life. Menopause is the longest life stage in a woman's life, in whic...

Eligibility Criteria

Inclusion

  • being able to read and write,
  • Not having a period for at least a year,
  • Not having any diagnosed psychiatric disease or not using medication,
  • Not using or not using hormone replacement therapy.

Exclusion

  • To have entered menopause with surgical methods,
  • Not participating in at least two group programs.

Key Trial Info

Start Date :

April 3 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 29 2023

Estimated Enrollment :

192 Patients enrolled

Trial Details

Trial ID

NCT05202054

Start Date

April 3 2022

End Date

January 29 2023

Last Update

April 11 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NURDİLAN

Elâzığ, Turkey (Türkiye), 23100

Insomnia and Mindfulness Stress Reduction Program | DecenTrialz